Next Article in Journal
Effects of Adenosine Extract from Pholiota adiposa (Fr.) Quel on mRNA Expressions of Superoxide Dismutase and Immunomodulatory Cytokines
Previous Article in Journal
Microwave-Enhanced Cross-Coupling Reactions Involving Alkynyltrifluoroborates with Aryl Bromides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant Capacity of Two Novel Bioactive Fe(III)-Cyclophane Complexes

by
Alex J. Salazar-Medina
1,
Rocío Sugich-Miranda
1,2,
Eli Teran-Cabanillas
2,
Jesús Hernández
2,
Gustavo A. González-Aguilar
2,
Enrique Rudiño-Piñera
3,
Rogerio R. Sotelo-Mundo
1,2,* and
Enrique F. Velázquez-Contreras
1,*
1
Departamento de Investigación en Polímeros y Materiales (DIPM), Universidad de Sonora, Calle Rosales y Blvd, Luis Encinas s/n, Col. Centro, PO Box 130. Hermosillo Sonora 83000, Mexico
2
Centro de Investigación en Alimentación y Desarrollo (CIAD), A.C. Carretera a Ejido La Victoria Km 0.6, PO Box 1735, Hermosillo Sonora 83304, Mexico
3
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México (IBT-UNAM) Av. Universidad #2001, Col. Chamilpa, Cuernavaca, Morelos 62250, Mexico
*
Authors to whom correspondence should be addressed.
Molecules 2013, 18(2), 1762-1774; https://doi.org/10.3390/molecules18021762
Submission received: 13 November 2012 / Revised: 6 January 2013 / Accepted: 7 January 2013 / Published: 29 January 2013

Abstract

:
The cyclophanes 2,9,25,32-tetraoxo-4,7,27,30-tetrakis(carboxymethyl)-1,4,7,10,24,27,30,33-octaaza-17,40-dioxa[10.1.10.1]paracyclophane (PO) and 2,9,25,32-tetraoxo-4,7,27,30-tetrakis(carboxymethyl)-1,4,7,10,24,27,30,33-octaaza[10.1.10.1]paracyclophane (PC) were coordinated with iron to form cationic binuclear Fe(III) Fe2PO and Fe2PC complexes, respectively. Their antioxidant capacity, superoxide dismutase and peroxidase mimetic activity, as well as their toxicity toward peripheral blood mononuclear cells (PBMCs) were evaluated. Both Fe2PO and Fe2PC are interesting biomimetics with antioxidant capacity similar to that of ascorbic acid that prevent mortality in cultured PBMCs, with the potential to have bioactive and protective functions in disease animal models.

1. Introduction

Reactive oxygen species (ROS) are toxic molecules implicated in several human pathological processes including tissue injury, inflammation, ageing, cancer, cardiovascular, pulmonary and neurodegenerative diseases [1]. Aside from many enzymatic and chemical antioxidants, several synthetic metal complexes have shown activity as biomimetic antioxidants [2]. Transition metal complexes [e.g., complexes of Mn(II), Mn(III), Cu(II) and Fe(III)] have important antioxidant properties [1], due to their ability to change their oxidation state and their chemical interactions with a wide number of negatively charged ions, radicals and molecules. These characteristics have prompted the design and development of metal-based drugs with promising pharmacological application which might offer unique therapeutic opportunities [3].
The first line of defense against ROS in cellular systems is superoxide dismutase (SOD), that catalyzes the conversion of O2•− to H2O2 and O2 [4]. Some macrocyclic complexes have been proposed as SOD mimetics, mainly because of their high thermal stability and flexible ligand arrangement that allows redox processes based on their metal centers [5]. The action of SOD produces H2O2 by the O2•− dismutation, a much less reactive molecule compared to O2•−, but still toxic to the cell. H2O2 in the presence of transition metals, it is rapidly converted via the Fenton reaction to the hydroxyl radical (OH). The OH is widely accepted to be the most damaging and cytotoxic ROS produced by cells. Two enzymes participate in the removal of H2O2 from the cellular environment, peroxidases (POx) and catalases (CAT), converting the H2O2 into water molecules and diatomic oxygen [6]. For these reasons we examined the use of Fe(III) ions coordinated to cyclophane ligands generating a new binuclear Fe(III)-cyclophane group of complexes, which could represent a new class of antioxidants. The study of these molecules will provide a deeper insight into the understanding of complexes that could mimic some enzymes related to ROS contention mechanisms.

2. Results and Discussion

2.1. Synthesis of the PO and PC Iron Complexes

The purified chelating cyclophanes 2,9,25,32-tetraoxo-4,7,27,30-tetrakis (carboxymethyl)-1,4,7,10,24,27,30,33-octaaza-17,40-dioxa[10.1.10.1] paracyclophane (PO) and 2,9,25,32-tetraoxo-4,7,27,30-tetrakis(carboxymethyl)-1,4,7,10,24,27,30,33-octaaza[10.1.10.1] paracyclophane (PC), were synthesized as previously reported [7]. Both molecules were derived from ethylenediaminetetraacetic acid (EDTA) and provided with amino, amide and carboxymethyl pendant donor groups. Their purity was confirmed by melting/decomposition point (MDP) and NMR studies (see Experimental section below). Reactions between FeCl3.6H2O (at pH ~ 3) and PO and PC (both at pH ≤ 7), gave binuclear Fe(III) complexes [Fe2L]2+, labeled Fe2PO and Fe2PC, respectively (Figure 1). We propose that PO and PC metal chelates have a structure in which each Fe atom is coordinated by two carboxylate oxygens, two amine nitrogens and two amide oxygen atoms, with a feasible water molecule axial coordinated in aqueous solutions, on the basis of the well-known ferric EDTA complexes [8] and the coordination mode found in the X-ray crystal structure of a related cyclophane (3,10,21,28-tetraoxo-5,8,23,26-tetrakis(carboxymethyl)-2,5,8,11,20,23,26,29-octaaza[12.12] paracyclophane) bound to zinc [9]. Fe2PO was soluble in aqueous solutions in a pH range from 4.2 to 10.0, while Fe2PC was soluble in aqueous solutions in a pH range from 5.2 to 10.0.
Figure 1. Chemical structures proposed of Fe2PO and Fe2PC cyclophane iron (III) complexes.
Figure 1. Chemical structures proposed of Fe2PO and Fe2PC cyclophane iron (III) complexes.
Molecules 18 01762 g001

2.2. Mass Spectrometry

To confirm the formation of the metal complexes, the mass spectra of methanol-water solutions of Fe2PO and Fe2PC were obtained. Fe2PO showed a major peak assigned to [Fe23+L4−]2+ specie at m/z = 510 with an abundance of 100%. Another peak that supports the formation of the binuclear Fe(III) complex correspond to [Fe23+L4−Cl2−] at m/z = 1,092 with an abundance of 6%. For Fe2PC a major peak assigned to [Fe23+L4−]2+ specie was observed at m/z = 508 with an abundance of 100%. Molecular ion peaks corresponding to mononuclear species [Fe3+L−4] were not detected for Fe2PO or Fe2PC.

2.3. Electron Paramagnetic Resonance (EPR)

The X-band EPR spectra observed for Fe2PO and Fe2PC in 60% aqueous methanol solutions at 6 K are shown in Figure 2. The spectra exhibit an intense peak at g ~ 4.3 in the region of 1,500 G, typical of high-spin (S = 5/2) iron(III) complexes with low symmetry, as well as commonly found in a variety of solid state materials, chelates and metallo proteins [10,11].
Figure 2. g values of the X-band EPR spectra for Fe2PO and Fe2PC. Experimental conditions: methanol/water (6:4) matrix, temperature 6 K, microwave frequency 9.338 GHz, modulation 1 G.
Figure 2. g values of the X-band EPR spectra for Fe2PO and Fe2PC. Experimental conditions: methanol/water (6:4) matrix, temperature 6 K, microwave frequency 9.338 GHz, modulation 1 G.
Molecules 18 01762 g002

2.4. Infrared Spectroscopy

The coordination mode for Fe2PO and Fe2PC complexes was analyzed by IR spectroscopy by comparison of absorption bands of the non-coordinated ligand vs. the metal complex (Figure 3). The stretching carbonyl bands gave shifts from 1,684 cm−1 (PO) to 1,620 cm−1 (Fe2PO) and 1,674 cm−1 (PC) to 1,624 cm−1 (Fe2PC). We also observed a broad OH band at the 3,200–3,600 cm−1 region. The changes in the position of the absorption bands of Fe-bound and unbound cyclophanes provide us an indicative of the formation of the metal complex and its preferred coordination sites in the ligand structures, as well as the observed for Fe(III)-EDTA complexes [8].
Figure 3. IR spectra for KBr pellets of (a) PO and Fe2PO (solid and dotted line respectively); and (b) PC and Fe2PC (solid and dotted line respectively).
Figure 3. IR spectra for KBr pellets of (a) PO and Fe2PO (solid and dotted line respectively); and (b) PC and Fe2PC (solid and dotted line respectively).
Molecules 18 01762 g003

2.5. Electronic Absorption Spectra

The electronic spectra for Fe2PO solution were pH dependent, as shown in Figure 4(a). In a pH range of 6.0 to 10.0 the spectra show two bands with a λmax of 350 nm (εpH7.0 = 11,830 M−1cm−1) and 475 nm (εpH7.0 = 4,680 M−1cm−1), assigned to a ligand-to-metal charge transferences (LMCT) [12]. With an increase of the pH, the molar absorptivity also increases, and the λmax of each band was slightly displaced to a major wavelengths. Above pH ~ 10, the molar absorptivity of the LMCT bands decreases due to the precipitation of the complex in the working solution. The data obtained in the UV-Vis experiment were analyzed through the program Excel® Worksheets for Spectrometry [13] and we determined the presence of different protonation state species of the Fe2PO complex [Figure 5(a)], where the non-deprotonated species Fe2L(H2O)2 reaches its maximum concentration at pH 6.0 and then start to decrease. Over this pH, the Fe2PO complex solution becomes into a dark red colored solution and the mono deprotonated species Fe2L(H2O)(OH) and bi deprotonated species Fe2L(OH)2 appears, to finally shift into a yellow colored suspension (precipitate complex) at pH 11.0. These spectrophotometric observations are consistent with those corresponding to the complex Fe(III)-EDTA [14].
Figure 4. Solution electronic spectra of (a) Fe2PO and (b) Fe2PC at different pH values. White and black circles spectra corresponded to unbound cyclophane and Fe(III) respectively, both at pH ~ 7, as a controls.
Figure 4. Solution electronic spectra of (a) Fe2PO and (b) Fe2PC at different pH values. White and black circles spectra corresponded to unbound cyclophane and Fe(III) respectively, both at pH ~ 7, as a controls.
Molecules 18 01762 g004
The electronic spectra of Fe2PC also present two LMCT bands, the first one at 307 nm (εpH7.0 = 8,710 M−1cm−1), and the second band at 334 nm (εpH7.0 = 6,270 M−1cm−1). In this case, the intensity of the two bands decreases with the augmentation of the pH [Figure 4(b)]. The same method of analysis was used to establish the presence of different protonation state species of Fe2PO, and it was utilized with the UV-Vis data spectra of Fe2PO complex [Figure 5(b)]. The non-deprotonated species Fe2L(H2O)2 moves its maximum concentration percentage from pH 6.0 for Fe2PO to pH 6.5 for Fe2PC and then starts to decrease. Over pH ≈ 8.0 the deprotonated species appears, Fe2L(H2O)(OH) and Fe2L(OH)2 , and the complex solution becomes a dark red colored solution, to finally shift into a yellow colored suspension due to the formation of the precipitate complex over pH 11.0, as well as that observed to Fe2PO.
As a consequence of the pH dependence mentioned above, a mixture of the species Fe2L(H2O)2 and Fe2L(H2O)(OH) of Fe2PO as well as Fe2PC, was present in each experiment described below (Figure 6).
Figure 5. Correlation between the species distribution and the absorption spectra of Fe2PO at top and Fe2PC at bottom. (% = Percentage of species distribution in solution).
Figure 5. Correlation between the species distribution and the absorption spectra of Fe2PO at top and Fe2PC at bottom. (% = Percentage of species distribution in solution).
Molecules 18 01762 g005
Figure 6. Changes in protonation state of the aqueous solutions of Fe2PO and Fe2PC complexes in dependence of pH.
Figure 6. Changes in protonation state of the aqueous solutions of Fe2PO and Fe2PC complexes in dependence of pH.
Molecules 18 01762 g006
The differences between the substituent groups X = -O- for Fe2PO and X = -CH2- for Fe2PC (Figure 1), provide the Fe(III) complexes with distinct properties, even with the no participation of the substituent groups in the coordination sphere with iron. X = -O- allows a major flexibility to Fe2PO against the Fe2PC, because the more rigidity property of X = -CH2- and this characteristic is responsible of the differences in the UV-Vis spectra behavior between Fe2PO and Fe2PC. Even though the two iron atoms coordinate to the same groups in PO and PC ligands, a higher tension was expected to Fe2PC complex to maintain the coordination. In addition, Fe2PO has shown major solubility in aqueous solution, letting us to study it at lower pHs than Fe2PC do. In the species distribution diagram we can see the non-protonated and protonates species of Fe2PO and Fe2PC appear at different pH values, behavior attributable to the structural rigidity in each metal complex.

2.6. Antioxidant Capacity Assay

The characterization of antioxidant capacity is of great importance because the multiple biological and medical applications of such synthetic molecules. The Fe2PO had more antioxidant capacity (0.0690 g eq Trolox mol−1) than Fe2PC (0.0443 g eq Trolox mol−1), both within the range of the antioxidant capacity presented by ascorbic acid at the same molar concentration (0.0755 g eq Trolox mol−1) (Figure 7). The behavior of the Fe(III) complexes was similar to the observed for the Cu(II) complexes reported by Sugich-Miranda and co-workers [5]. The difference between Fe2PO and Fe2PC antioxidant capacity could be due to differences in conformational flexibility of Fe2PC, resulting in a less favorable interaction with the ABTS•+ radicals in solution causing a lower antioxidant capacity. The antioxidant capacity of iron (FeCl3) was undetectable in the TEAC assay.
Figure 7. Antioxidant capacity of Fe2PO and Fe2PC complexes by the TEAC assay. Ascorbic acid and a solution of Fe(III) were used as a controls. Bars represent the standard error of the mean (±SEM) of triplicate experiments. Ferric chloride had no detectable antioxidant capacity and was not plotted.
Figure 7. Antioxidant capacity of Fe2PO and Fe2PC complexes by the TEAC assay. Ascorbic acid and a solution of Fe(III) were used as a controls. Bars represent the standard error of the mean (±SEM) of triplicate experiments. Ferric chloride had no detectable antioxidant capacity and was not plotted.
Molecules 18 01762 g007

2.7. Superoxide Dismutase-Like Activity

The SOD-like activity was measured by inhibition of the oxidation of nitrobluetetrazolium (NBT) induced by the presence of the O2•− radical generated by the xanthine and xanthine oxidase enzymatic system. We tested bovine SOD as the main scavenger of O2•− radical, producing 89.40% of NBT oxidation inhibition with a 60 µM concentration of the enzyme. Under the same conditions the NBT oxidation inhibition of Fe2PO was 39.53% and for Fe2PC was 41.97% (Figure 8). The values obtained of both metal complexes, reaches over a 44% of NBT oxidation inhibition generated by bovine SOD.
Figure 8. SOD-like activities of Fe2PO and Fe2PC complexes as inhibitors of the NBT oxidation. Bars represent the standard error of the mean (±SEM) of triplicate values.
Figure 8. SOD-like activities of Fe2PO and Fe2PC complexes as inhibitors of the NBT oxidation. Bars represent the standard error of the mean (±SEM) of triplicate values.
Molecules 18 01762 g008

2.8. Peroxidase-Like Activity

In order to investigate the bioactive capacity as a POx mimetic, the POx-like activity of Fe2PO and Fe2PC complexes was determined using the Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit. The results observed were 0.13 and 0.29 nm of Amplex® Red oxidized min−1 mg−1 complex for Fe2PO and Fe2PC, respectively. Both Fe2PO and Fe2PC complexes kept the POx-like activity for about 48 h, as observed with a continuous oxidation of the Amplex® Red reagent in presence of H2O2 (Figure 9). This prolonged capacity of Fe2PO and Fe2PC to act as a POx mimetic towards H2O2 is desirable in a chemical with pharmacological properties. For example, the HRPO, as the main peroxidase tested in this assay, was only active in vitro for 30 min, compared to the 48 h of the cyclophane biomimetic complexes. Likewise, for a hemoglobin recombinant protein of the plant Arabidopsis thaliana, another class of POx mimetic, a rapid inactivation was observed after 30 s, although the great initial specific activity [15]. Therefore, the study of the possible mechanisms of these mimetic chemicals will give useful knowledge for the medical and pharmacological area.
Figure 9. Peroxidase-like activity of ● FeCl3, ■ PO, PC, Fe2PO and ♦ Fe2PC. Bars represent the standard error of the mean (±SEM) of triplicate values.
Figure 9. Peroxidase-like activity of ● FeCl3, ■ PO, PC, Fe2PO and ♦ Fe2PC. Bars represent the standard error of the mean (±SEM) of triplicate values.
Molecules 18 01762 g009

2.9. Cellular Assay

To evaluate the bio-protective effect of Fe(III)-cyclophane complexes, different concentrations of Fe2PO and Fe2PC (30, 60 and 120 µM) were incubated with PBMCs in the presence of xanthine plus xanthine oxidase to generate reduced species of oxygen and induce cell damage. The percentage of mortality was evaluated by trypan blue dye exclusion assay. Figure 10(a) shows that Fe2PO reduced mortality percentage in all the concentrations probed from 10.6% in control untreated cells to 5.06% with the highest concentration (120 µM) tested, after 24 h of culture. A similar trend was for Fe2PC [Figure 10(b)], reducing the mortality from 10.7% in control untreated cells to 4.70% with the highest concentration tested, after 24 h of culture. We previously evaluated the toxicity after 24 h culture of the Fe(III)-cyclophane complexes and the highest percentages of mortality for Fe2PO and Fe2PC was 0.9% and 0.5%, respectively. These results are similar to those previously reported by our group [5], where we found no toxic but a protective effect of the Cu2PO and Cu2PC in PBMCs by reducing mortality in 6% compared to control untreated cells. These results indicate that both cyclophane-Fe(III) complexes were not cytotoxic during the first 24 h of culture, even when high doses were used. Therefore, these molecules could be considered as potential candidates for further antioxidant studies using animal models and cancer cell lines in order to probe its possible beneficial effects. Over 24 h of culture the cell mortality increases because lacking of nutrients in the culture medium.
Figure 10. Cellular protection of (a) Fe2PO and (b) Fe2PC in PBMCs with induced damage by ROS. The line marked as blank corresponds to PBMCs in RPMI medium with no treatment. Data comes from a representative experiment. Points represent the standard error of the mean (±SEM) of triplicate values.
Figure 10. Cellular protection of (a) Fe2PO and (b) Fe2PC in PBMCs with induced damage by ROS. The line marked as blank corresponds to PBMCs in RPMI medium with no treatment. Data comes from a representative experiment. Points represent the standard error of the mean (±SEM) of triplicate values.
Molecules 18 01762 g010

3. Experimental

3.1. Syntheses of Cyclophanes and Iron Complexes

PO was synthesized by adding bis(4-aminophenyl) ether (Aldrich, 1.5 g) in dimethylformamide (DMF, 70 mL) dropwise to ethylenediamine tetraacetic (EDTA) dianhydride (Aldrich, 2.0 g) in DMF (200 mL) under a nitrogen atmosphere. The light yellow solution obtained was concentrated and mixed with water, and a pale brown solid was obtained. This crude cyclophane was converted to the lithium salt, and recrystallized twice from hot water. Acidification (pH ~ 3) of the purified lithium salt gave PO in the acid form as a colorless solid. Yield: 15%. MDP: 262.0 °C. The absence of impurities such as oligomers was confirmed by 1H-NMR (D2O/Na2CO3, pD = 9.5, 400 MHz, DSS): δH = 2.86 (8H, s, Hb), 3.29 (8H, s, Ha), 3.43 (8H, s, Hc), 6.85 (8H, d, He), 7.18 (8H, d, Hd).
PC was synthesized by essentially the same method as for PO by the use of the diamine bis (4-aminophenyl)methane (Aldrich). The crude product was converted to the lithium salt, which was recrystallized from 50% ethanol. When an aqueous solution of the purified lithium salt was acidified with diluted HCl to pH ~ 3, PC in the acid form was obtained as a colorless solid. The product was washed with water. Yield: 12%. MDP: 256.0 °C. 1H-NMR (D2O, pD = 10.4; 400 MHz; DSS): δH = 2.81 (8H, s, Hb); 3.28 (8H, s, Ha), 3.38 (8H, s, Hc), 3.78 (4H, s, Hf), 6.98 (8H, d, He), 7.12 (8H, d, Hd).
To obtain the iron (III) complexes, each host molecule (either PO or PC) was dissolved in water and solubilized by adding a minimum amount of solid Na2CO3. This solution was added to an aqueous solution containing a slight excess of FeCl3·6H2O, the binuclear iron complex precipitated in a quantitative yield. The melting decomposition point (MDP) was obtained in a Mel-Temp II equipment (Laboratory Devices). The electrospray ionization (ESI) mass spectra were obtained by the use of a JEOL HX 110A spectrometer for sample solutions of methanol-water mixture.
Fe2PO. MDP: 301.7 °C. MS (ESI): m/z (for (C44H44Fe2N8O14)2+) = 510 (100) ([Fe23+L4−]2+);
Fe2PC. MDP: 283.8 °C. MS (ESI): m/z (for (C46H48Fe2N8O12)2+) = 508 (100) ([Fe23+L4−]2+).

3.2. Spectroscopic Measurements

The EPR spectra of the binuclear Fe(III) complexes were obtained on an X-band continuous wave Elexsys E500 (Bruker) EPR spectrometer, for 60% aqueous methanol solutions. The final concentration of each complex was approximately 1 mM. Infrared spectra were recorded on a Perkin Elmer Spectrum GX FT-IR system, in the range 4,000–400 cm−1. The samples were prepared as KBr pellets. The solution electronic spectra were obtained by the use of an Agilent 8453A UV-VIS diode array spectrometer. The pH of the samples solutions was adjusted by adding the necessary amount of NaOH solution. The species distributions were determined using the data obtained in the UV-Vis analysis varying the pH, with the program Excel® Worksheets for Spectrometry [13].

3.3. Antioxidant Capacity Assay

The Trolox equivalent antioxidant capacity (TEAC) assay is based on determination of Trolox-equivalents, which is a water-soluble analog of vitamin E. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2carboxylic acid) was purchased from Aldrich (Milwaukee, WI, USA). ABTS (2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid), potassium persulfate (K2S2O8) and ascorbic acid (vitamin C) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). All other reagents were analytical grade or better. Fe2PO and Fe2PC complexes were evaluated at 30 and 60 µM concentrations using a modified TEAC method to determine their antioxidant activity. The TEAC method measures the antioxidant capacity to scavenging the blue-green ABTS•+ radical cation versus the scavenging capacity of Trolox. The radical cation ABTS•+ was obtained by mixing 5 mL of 7 mM ABTS solution and 88 µL of a 140 mM K2S2O8 solution. One milliliter of the ABTS•+ was dissolved in 88 mL of PBS. In a quartz cell, the reaction contained 245 µL of an ABTS•+ and 5 µL of each test sample or dilutions of the Trolox standards. The absorbance was read within 80 min after the initial mixing. Calculations were made correlating the scavenging capacity of Trolox versus each sample. The antioxidant capacity was expressed as grams equivalent Trolox per mol of test sample.

3.4. Superoxide Dismutase-Like Activity

SOD activity was determined according to Beyer and Fridovich [16] with slight modifications as follows: the stock solution consisted of 2 mM xanthine (50 µL), 0.3% Triton X-100 solution (50 µL), 1.2 mM nitrobluetetrazolium (NBT, 50 µL), 0.1 mM phosphate buffer solution (770 µL, pH 7.8) and xanthine oxidase enzyme (600 mU mL−1, 20 µL) to start the reaction; 1 mM (60 µL) of each sample, Fe2PO or Fe2PC (for a final concentration of 60 µM) were added to the quartz cell by triplicate. Then, the quartz cell was mounted into a UV-visible spectrophotometer (Varian), and the absorbance was measured (at 540 nm for 5 min) as absorbance increment due to NBT formation per unit of time. Assays were performed at room temperature (25 °C). We reported the inhibition percentage of tetrazolium formazan formation, under the conditions describe above.

3.5. Peroxidase-Like Activity

POx activity was determined using the Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit. The assay consisted in placing into individual wells of a microplate 50 µL of working solution prepared as follows: 10 mM Amplex® Red (10-acetyl-3,7-dihydroxyphenoxazine) reagent stock solution (50 µL), 20 mM H2O2 solution (500 µL) and 1X Reaction Buffer (4.45 mL) and Fe2PO or Fe2PC (50 µL) were added with a final concentration of 0.1 mM. The POx activity was determined spectrophotometrically monitoring the oxidation of the Amplex® Red reagent to Resourfin in the presence of H2O2 and a POx or POx mimetic, using a microplate reader at 550 nm after 0.5, 12, 24 and 48 h of incubation.

3.6. Cellular Assay

PBMCs were isolated from heparinized blood obtained from human healthy donors by a density gradient centrifugation using Ficoll-Hypaque. Isolated PBMCs (5 × 105 cells per well) were resuspended in RPMI-1640 medium containing 10% heat-inactivated fetal calf serum, 50 mM 2-mercapoethanol, 100 U mL−1 amphotericin band seeded onto 96-well tissue culture plates for stimulation with phytohemagglutinin (PHA, 5 µg mL−1) in the presence of enzymatic system, xanthine plus xanthine oxidase (XO), as an enzymatic generator of reactive oxygen species, i.e., superoxide, hydrogen peroxide and hydroxyl radicals [16] (8 mM of xanthine and 23 mU mL−1 XO), and a different concentrations of Fe2PO and Fe2PC (0, 30, 60 and 120 µM). Cells were incubated 6, 18 and 24 h at 37 °C in 5% CO2. Cell viability was evaluated by trypan blue dye exclusion assay.

4. Conclusions

Two novel Fe(III)-cyclophanes have shown bioactive properties as antioxidants, reducing the synthetic ABTS•+ radical, within the range observed for ascorbic acid, which was used as the reference antioxidant. Reported results for similar Cu(II) complexes [5] demonstrated the biomimetic potential of these metallic cyclophane derivatives [7]. Aside of their antioxidant capacity comparable to phenolic acids, flavonoids and vitamins C and E [17] is the lack of need for negative interactions with cells. For that matter, a bioassay using PBMC cells injured with ROS was done to test their antioxidant capacity in vivo. In fact, both Fe2PO and Fe2PC were able to scavenge the superoxide produced by xanthine and xanthine oxidase, leading to an increased cellular survival.
The differences in biomimetic activity between Fe2PO and Fe2PC could be due to structural differences between the cyclophanes. The action of iron-cyclophanes against the superoxide radical was similar in the SOD assay, while when a stable radical (ABTS) was used to test antioxidant capacity, Fe2PO was better than Fe2PC. It is known that PC is more rigid compared to PO, and since ABTS is a large molecule with a mass over 500 Da, we postulate that steric effects arise at the interaction with the synthetic antioxidant. Considering that these molecules could remove superoxide radical and led to molecular water that not affect cells, they appear to be very interesting molecules for further studies to evaluate their antioxidant and bioactive properties in animal models and cancer cell lines.

Acknowledgments

Alex Salazar-Medina and Eli Teran-Cabanillas are thankful for a Ph.D. scholarship from CONACYT. This project was partially funded by grant IPYM11/I157 from División de Ingeniería, Universidad de Sonora. R. Sotelo-Mundo is on sabbatical leave at Universidad de Sonora, Departamento de Investigación en Polimeros y Materiales, Universidad de Sonora.
  • Sample Availability: Samples of the compounds PO, PC, Fe2PO and Fe2PC are available from the authors.

References

  1. Fernandes, A.S.; Gaspar, J.; Cabral, M.F.; Caneiras, C.; Guedes, R.; Rueff, J.; Castro, M.; Costa, J.; Oliveira, N.G. Macrocyclic copper (II) complexes: Superoxide scavenging activity, structural studies and cytotoxicity evaluation. J. Inorg. Biochem. 2007, 101, 849–858. [Google Scholar] [CrossRef]
  2. Jakab, I.N.; Lrincz, O.; Jancsó, A.; Gajda, T.; Gyurcsik, B. Approaching the minimal metal ion binding peptide for structural and functional metalloenzyme mimicking. Dalton Trans. 2008, 2008, 6987–6995. [Google Scholar]
  3. Rafique, S.; Idrees, M.; Nasim, A.; Akbar, H.; Athar, A. Transition metal complexes as potential therapeutic agents. Biotechnol. Mol. Biol. Rev. 2010, 5, 38–45. [Google Scholar]
  4. Muscoli, C.; Cuzzocrea, S.; Riley, D.P.; Zweier, J.L.; Thiemermann, C.; Wang, Z.Q.; Salvemini, D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol. 2003, 140, 445–460. [Google Scholar] [CrossRef]
  5. Sugich-Miranda, R.; Sotelo-Mundo, R.R.; Silva-Campa, E.; Hernández, J.; Gonzalez-Aguilar, G.A.; Velazquez-Contreras, E.F. Antioxidant capacity of binuclear Cu (II)-Cyclophanes, insights from two synthetic bioactive molecules. J. Biochem. Mol. Toxicol. 2010, 24, 379–383. [Google Scholar]
  6. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolin, I.; Herrera, F.; Martin, V.; Reiter, R.J. Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 2004, 36, 1–9. [Google Scholar] [CrossRef]
  7. Inoue, M.B.; Velazquez, E.F.; Medrano, F.; Ochoa, K.L.; Galvez, J.; Inoue, M.; Fernando, Q. Binuclear copper (II) chelates of amide-based cyclophanes. Inorg. Chem. 1998, 37, 4070–4075. [Google Scholar]
  8. Kanamori, K.; Dohniwa, H.; Ukita, N.; Kanesaka, I.; Kawai, K. The raman spectral study on the solution structure of iron (III)-EDTA complexes. Bull. Chem. Soc. Jpn. 1990, 63, 1447–1454. [Google Scholar] [CrossRef]
  9. Inoue, M.B.; Medrano, F.; Inoue, M.; Raitsimring, A.; Fernando, Q. A New Chelating Cyclophane and Its Complexation with Ni2+, Cu2+, and Zn2+: Spectroscopic Properties and Allosterism via Ring Contraction. Inorg. Chem. 1997, 36, 2335–2340. [Google Scholar]
  10. Bou-Abdallah, F.; Chasteen, N.D. Spin concentration measurements of high-spin (g' = 4.3) rhombic iron (III) ions in biological samples: Theory and application. J. Biol. Inorg. Chem. 2008, 13, 15–24. [Google Scholar] [CrossRef]
  11. Namuswe, F.; Hayashi, T.; Jiang, Y.; Kasper, G.D.; Sarjeant, A.A.N.; Moënne-Loccoz, P.; Goldberg, D.P. Influence of the Nitrogen Donors on Nonheme Iron Models of Superoxide Reductase: High-Spin FeIII-OOR Complexes. J. Am. Chem. Soc. 2009, 132, 157–167. [Google Scholar]
  12. Dhungana, S.; Heggemann, S.; Gebhardt, P.; Möllmann, U.; Crumbliss, A.L. Fe (III) coordination properties of a new saccharide-based exocyclic trihydroxamate analogue of ferrichrome. Inorg. Chem. 2003, 42, 42–50. [Google Scholar] [CrossRef]
  13. Ronaghi, M. Excel® Worksheets for Spectrometry 2012; Universidad de Sonora: Hermosillo, Sonora, México, 2012. [Google Scholar]
  14. Bull, C.; McClune, G.J.; Fee, J.A. The mechanism of iron EDTA catalyzed superoxide dismutation. J. Am. Chem. Soc. 1983, 105, 5290–5300. [Google Scholar] [CrossRef]
  15. Sakamoto, A.; Sakurao, S.; Fukunaga, K.; Matsubara, T.; Ueda-Hashimoto, M.; Tsukamoto, S.; Takahashi, M.; Morikawa, H. Three distinct Arabidopsis hemoglobins exhibit peroxidase-like activity and differentially mediate nitrite-dependent protein nitration. FEBS Lett. 2004, 572, 27–32. [Google Scholar] [CrossRef]
  16. Beyer, W.F.; Fridovich, I. Assaying for superoxide dismutase activity: Some large consequences of minor changes in conditions. Anal. Biochem. 1987, 161, 559–566. [Google Scholar] [CrossRef]
  17. Aispuro-Hernandez, E.; Garcia-Orozco, K.D.; Muhlia-Almazan, A. Shrimp thioredoxin is a potent antioxidant protein. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2008, 148, 94–99. [Google Scholar]

Share and Cite

MDPI and ACS Style

Salazar-Medina, A.J.; Sugich-Miranda, R.; Teran-Cabanillas, E.; Hernández, J.; González-Aguilar, G.A.; Rudiño-Piñera, E.; Sotelo-Mundo, R.R.; Velázquez-Contreras, E.F. Antioxidant Capacity of Two Novel Bioactive Fe(III)-Cyclophane Complexes. Molecules 2013, 18, 1762-1774. https://doi.org/10.3390/molecules18021762

AMA Style

Salazar-Medina AJ, Sugich-Miranda R, Teran-Cabanillas E, Hernández J, González-Aguilar GA, Rudiño-Piñera E, Sotelo-Mundo RR, Velázquez-Contreras EF. Antioxidant Capacity of Two Novel Bioactive Fe(III)-Cyclophane Complexes. Molecules. 2013; 18(2):1762-1774. https://doi.org/10.3390/molecules18021762

Chicago/Turabian Style

Salazar-Medina, Alex J., Rocío Sugich-Miranda, Eli Teran-Cabanillas, Jesús Hernández, Gustavo A. González-Aguilar, Enrique Rudiño-Piñera, Rogerio R. Sotelo-Mundo, and Enrique F. Velázquez-Contreras. 2013. "Antioxidant Capacity of Two Novel Bioactive Fe(III)-Cyclophane Complexes" Molecules 18, no. 2: 1762-1774. https://doi.org/10.3390/molecules18021762

APA Style

Salazar-Medina, A. J., Sugich-Miranda, R., Teran-Cabanillas, E., Hernández, J., González-Aguilar, G. A., Rudiño-Piñera, E., Sotelo-Mundo, R. R., & Velázquez-Contreras, E. F. (2013). Antioxidant Capacity of Two Novel Bioactive Fe(III)-Cyclophane Complexes. Molecules, 18(2), 1762-1774. https://doi.org/10.3390/molecules18021762

Article Metrics

Back to TopTop